FIRST CITIZENS BANK & TRUST CO - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 281 filers reported holding HAEMONETICS CORP in Q4 2018. The put-call ratio across all filers is 2.89 and the average weighting 0.1%.

Quarter-by-quarter ownership
FIRST CITIZENS BANK & TRUST CO ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q1 2021$299,000
+30.6%
2,694
+39.8%
0.01%
+16.7%
Q4 2020$229,000
+6.0%
1,927
+12.6%
0.01%0.0%
Q4 2019$216,0000.0%1,7110.0%0.01%
-53.8%
Q3 2019$216,000
-43.3%
1,711
-46.0%
0.03%
-38.1%
Q2 2019$381,000
+38.0%
3,170
+0.3%
0.04%
+35.5%
Q1 2019$276,000
+20.0%
3,160
+37.7%
0.03%
+10.7%
Q4 2018$230,0002,2950.03%
Other shareholders
HAEMONETICS CORP shareholders Q4 2018
NameSharesValueWeighting ↓
LGT CAPITAL PARTNERS LTD. 1,216,059$64,500,0001.72%
HEARTLAND ADVISORS INC 406,192$21,544,0001.26%
KINGDON CAPITAL MANAGEMENT, L.L.C. 200,000$10,608,0001.22%
Aurora Investment Counsel 32,149$1,705,0001.01%
Endurant Capital Management LP 73,914$3,920,0000.95%
KINGDON CAPITAL MANAGEMENT, L.L.C. 135,000$7,160,0000.82%
ARMISTICE CAPITAL, LLC 872,000$46,251,0000.76%
Summit Creek Advisors LLC 131,357$6,967,0000.70%
Dean Capital Management 15,309$812,0000.70%
Keene & Associates, Inc. 11,720$622,0000.54%
View complete list of HAEMONETICS CORP shareholders